Study guide

IBD treatment, coeliac disease and IBS

AMC CAT MCQ Examination AMC Part 1

Track your progress as you read

Finished sections get a check mark.

1 Acute Coronary Syndromes & ECG Localization

ACS recognition and ECG localisation Reperfusion and infarction complications

2 Heart Failure, Cardiogenic Shock & Cardiac Arrhythmias

Heart failure assessment and treatment Arrhythmias and conduction emergencies

3 Systemic Hypertension & Peripheral Vascular Disease

Blood pressure and cardiovascular risk Secondary hypertension and arterial disease

4 Valvular Heart Disease, Infective Endocarditis & Pericarditis

Aortic and mitral valve disease Endocarditis and pericardial emergencies

5 Asthma & COPD Acute Flares and Maintenance

Asthma and COPD diagnosis and maintenance Acute asthma and COPD exacerbations

6 Pneumonia, pleural disease and respiratory failure

Pneumonia and infected pleural collections Pulmonary embolism, effusions and pneumothorax Respiratory failure, ARDS and sepsis

7 GI bleeding, bowel inflammation and malabsorption

GI bleeding assessment and resuscitation Varices, ulcers, reflux and lower GI bleeding IBD patterns and severe colitis assessment IBD treatment, coeliac disease and IBS

8 Chronic Liver Disease, Cirrhosis Complications & Acute Hepatitis

Cirrhosis diagnosis and prognosis Decompensation, viral hepatitis and surveillance

9 Diabetes, thyroid and adrenal disease

Diabetes diagnosis and ongoing care DKA, HHS and complication monitoring Thyroid disease assessment Thyroid emergencies and adrenal disease

10 Acute Kidney Injury, Chronic Kidney Disease & Fluid/Electrolyte Emergencies

AKI and chronic kidney disease Potassium and sodium emergencies

11 Anaemias, Inflammatory Arthropathies & Geriatric Comprehensive Assessment

Anaemia, bruising and blood disorders Arthritis, autoimmune disease and geriatric care

12 Evaluation of the Acute Abdomen, Peritonitis & Appendicitis

Abdominal pain, peritonitis and resuscitation Appendicitis diagnosis and treatment Perforation and mesenteric ischaemia

13 Small and Large Bowel Obstruction & Colorectal Surgical Pathology

Small bowel obstruction Colonic obstruction, volvulus and cancer recognition Colorectal care, diverticulitis and anorectal symptoms

14 Gallbladder Disease, Biliary Tract Infections & Acute Pancreatitis

Gallstones and biliary obstruction Cholangitis and pancreatitis diagnosis Pancreatitis severity and treatment

15 Advanced Trauma Life Support, Primary Survey & Life-Threatening Thoracic Injuries

Trauma primary survey and adjuncts Chest trauma and immediate threats

16 Traumatic Brain Injury, Intracranial Haemorrhage & Spinal Cord Clearance

Head injury, imaging and haemorrhage Herniation and spinal cord injury

17 Major Fractures, Joint Dislocations & Acute Compartment Syndrome

Fracture assessment and open injuries Compartment syndrome, dislocations and pelvic injury

18 Thermal Burns, Haemorrhagic Shock Resuscitation & Surgical Wound Care

Burn assessment and fluid resuscitation Bleeding shock, wound care and tetanus

19 Aortic Aneurysms & Acute Arterial Limb Ischaemia

Aneurysm recognition and planned care Ruptured aneurysm and acute limb ischaemia

20 Urological Emergencies, Testicular Torsion & Haematuria Investigation

Retention, stones and obstructed infection Scrotal pain and haematuria

21 Preoperative Risk Stratification & Postoperative Surgical Complications

Preoperative assessment and medicines Postoperative complications and prevention

22 Early Pregnancy Bleeding, Ectopic Pregnancy & Antenatal Screening

Miscarriage and ectopic pregnancy Antenatal screening and early-pregnancy comparisons

23 Hypertensive Disorders of Pregnancy & Medical Complications in Pregnancy

Pregnancy hypertension and preeclampsia Eclampsia, HELLP and antepartum bleeding

24 Intrapartum Monitoring, Postpartum Haemorrhage & Obstetric Emergencies

Labour physiology and CTG assessment CTG response and postpartum haemorrhage Obstetric emergencies and preterm birth

25 Abnormal Uterine Bleeding, Pelvic Pain & Endometriosis

Abnormal bleeding and structural causes Endometrial sampling and endometriosis PCOS diagnosis and long-term care

26 Contraception, Emergency Contraception & Pregnancy Termination

Contraceptive choice and missed pills Emergency contraception and abortion

27 Australian Cervical Screening Program & Gynaecological Malignancies

Cervical screening and cervical cancer Endometrial and ovarian cancer

28 Neonatal Resuscitation, Congenital Conditions & Neonatal Jaundice

Newborn resuscitation, Apgar and cyanosis Neonatal jaundice assessment Jaundice treatment and congenital screening

29 Developmental Milestones, Growth Charts & Failure to Thrive

Developmental milestones Regression, autism and support Faltering growth and developmental comparisons

30 The Limping Child, Septic Arthritis vs Transient Synovitis & Paediatric Hip Conditions

Limp assessment and septic-joint risk Joint-infection management and Perthes disease SUFE and paediatric hip comparisons

31 Croup, Bronchiolitis, Paediatric Asthma & Anaphylaxis

Croup Bronchiolitis Paediatric asthma Paediatric anaphylaxis

32 Evaluation of the Febrile Child, Sepsis & Meningococcal Disease

Febrile neonates and young infants Meningococcal disease and paediatric sepsis Bacterial meningitis and CSF interpretation Kawasaki disease and follow-up

33 Paediatric Surgical Abdomen, Dehydration & Child Protection / Non-Accidental Injury

Pyloric stenosis Intussusception and dehydration Child protection and injury assessment

34 The Mental State Examination & Suicide Risk Stratification

Mental state examination and psychotic symptoms Suicide formulation and mental health law

35 Major Depressive Disorder, Bipolar Affective Disorder & Mood Stabilisers

Depression assessment and treatment Serotonin toxicity and bipolar presentations Mood stabilisers and ECT

36 Generalised Anxiety, Panic Disorder, PTSD & Obsessive-Compulsive Disorder

Anxiety, panic and agoraphobia OCD and trauma-related disorders

37 Schizophrenia, Acute Psychosis & Antipsychotic Management

Psychosis assessment and antipsychotics Clozapine and severe adverse effects

38 Substance Use Disorders & Acute Withdrawal Syndromes

Substance disorders and alcohol withdrawal Wernicke disease, opioids and stimulants

39 Delirium vs Dementia, Perinatal Mood Disorders & Paediatric Psychiatry

Delirium and dementia assessment Cognitive behaviour, perinatal and childhood psychiatry

40 Medicare, PBS, AHPRA & Good Medical Practice Framework

Australian health services and Medicare PBS access and professional registration Professional boundaries and notifications

41 Informed Consent (Rogers v Whitaker), Mental Capacity & Involuntary Treatment

Consent, material risks and young people Capacity, refusal and substitute decisions

42 Patient Privacy, Confidentiality Exceptions & Mandatory Notifications

Privacy, disclosure and child reporting Driving fitness and threat disclosure

43 First Nations health and preventive care

First Nations health, determinants and cultural safety Community care, Item 715 and CTG medicines Immunisation and cancer screening entry points Screening pathways and primary CVD prevention

44 Epidemiological Metrics, Clinical Study Designs & Notifiable Communicable Diseases

Epidemiology, calculations, bias and surveillance

45 Neurological presentations

Stroke, TIA and focal weakness Headache, facial pain and vertigo Seizures, collapse and altered consciousness Numbness, movement disorders and generalised weakness

46 Musculoskeletal pain

Back, neck, bone and soft tissue pain

47 Eye presentations

Altered vision and retinal disease Red eye, ocular injury and discharge

48 Ear, nose, throat and oral health

Ear pain, hearing loss and tinnitus Nasal problems, neck lumps, hoarseness and dysphagia Toothache, mouth symptoms, dry mouth and halitosis

49 Skin, hair and nails

Rash, itch, infection and skin ulcers Skin lesions, hair loss and nail abnormalities

50 Breast health and feeding

Breast lumps, discharge and breastfeeding problems

51 Sexual and reproductive presentations

Genital symptoms, discharge and pelvic infection Menopause, prolapse and urinary symptoms Infertility and sexual dysfunction

52 Palliative care and carers

The dying patient, symptoms and carers

53 Eating disorders and personality care

Eating disorders, obesity and weight change Personality difficulties, self-harm and complex care

54 Sleep presentations

Insomnia, snoring and daytime sleepiness

55 Poisoning, resuscitation and environmental emergencies

Poisoning, toxidromes and antidote decisions Cardiopulmonary arrest, choking and emergency help Bites, stings, heat, cold and drowning

56 Communication, rights and professional practice

Communication, handover, errors and complaints Healthcare rights, inclusive care and equitable access Certificates, deaths, CPD and supervision Telehealth, images, prescribing and doctors' health

57 Genetics, research and donation

Genetic testing, research and organ donation

58 Travel, fever and outbreaks

Fever, travellers and outbreak response

IBD treatment, coeliac disease and IBS

Key Takeaways Explain This Topic AI

The Oxford day-three rule supports escalation decisions in acute severe ulcerative colitis.

Coeliac testing should occur while the patient consumes gluten.

Adult coeliac diagnosis generally requires specialist assessment and duodenal histology.

Last updated: October 2026

Medical and Surgical Treatment Algorithm

AMC Surgical Pearl: When medical therapy fails in ASUC, the emergency procedure of choice is a subtotal colectomy with end ileostomy and preservation of the rectal stump (Hartmann's pouch) . Proctectomy and pelvic dissection (ileal pouch reconstruction) are strictly avoided in acute sepsis, malnutrition, and high-dose corticosteroid exposure.

Coeliac Disease & Malabsorption

Coeliac disease is a systemic immune-mediated enteropathy triggered by the ingestion of dietary gluten (prolamins found in wheat, rye, and barley) in genetically susceptible individuals expressing HLA-DQ2 ( > 90 − 95 % > 90-95\% > 90 − 95% ) or HLA-DQ8 ( 5 − 10 % 5-10\% 5 − 10% ).

Clinical Presentation

Classical Presentation: Chronic diarrhoea, steatorrhoea, abdominal distension, flatulence, weight loss, and severe nutrient malabsorption.

Non-Classical / Adult Presentation (More Common): Lethargy, chronic fatigue, unexplained iron deficiency anaemia (microcytic, resistant to oral iron supplementation), early-onset osteopenia/osteoporosis, recurrent aphthous stomatitis, elevated transaminases, and recurrent miscarriages.

Dermatitis Herpetiformis: Cutaneous manifestation of coeliac disease presenting with intensely pruritic, symmetrical polymorphic vesicles, papules, and urticarial plaques over the extensor surfaces of the elbows, knees, buttocks, and scalp. Granular IgA deposition is noted in dermal papillae on direct immunofluorescence. Diagnosis confirms coeliac disease without mandatory bowel biopsy.

Diagnostic Algorithm & Serology Rules

Active Gluten Consumption Mandatory: All serological and histological testing must be performed while the patient is on a gluten-containing diet (consuming at least 2 slices of wheat bread daily for at least 6 weeks). Commencing a gluten-free diet before testing causes rapid serological normalization and mucosal healing, producing false-negative results.

First-Line Serological Screen:

Anti-Tissue Transglutaminase IgA (anti-tTG IgA)

Simultaneous Total Serum IgA Measurement: Selective IgA deficiency occurs in 2 − 3 % 2-3\% 2 − 3% of coeliac patients (a 10- to 15-fold higher incidence than in the general population). In total IgA deficiency, anti-tTG IgA is falsely negative. When total IgA is low ( < 0.07 g/L < 0.07\text{ g/L} < 0.07 g/L ), clinicians must order IgG-based serology: anti-deamidated gliadin peptide IgG (anti-DGP IgG) or anti-tTG IgG .

Confirmatory Gold Standard (Adults):

Gastroscopy with Duodenal Biopsies: Multiple biopsies must be obtained (at least 1-2 from the duodenal bulb and at least 4 from the second/third parts of the duodenum) to account for patchy involvement.

Marsh Histopathological Classification:

Marsh 1 (Infiltrative): Increased intraepithelial lymphocytes ( > 25 lymphocytes per 100 enterocytes > 25\text{ lymphocytes per } 100\text{ enterocytes} > 25 lymphocytes per 100 enterocytes ).

Marsh 2 (Hyperplastic): Intraepithelial lymphocytosis plus crypt hyperplasia.

Marsh 3 (Destructive): Crypt hyperplasia plus villous blunting/atrophy (3a partial, 3b subtotal, 3c total villous atrophy).

HLA-DQ2 / HLA-DQ8 Genotyping: Possesses a negative predictive value > 99 % > 99\% > 99% . A negative result effectively excludes coeliac disease. Indicated when serology and histology are discordant or when a patient has already commenced a gluten-free diet and refuses a gluten challenge.

Long-Term Management

Oats in coeliac disease: Australian gluten-free labelling excludes oats. Some patients react to avenin; contamination is another concern. Any introduction requires specialist dietitian guidance and follow-up, not a blanket statement that pure oats are non-immunogenic.

Nutritional correction: Oral or parenteral supplementation of iron, folate, calcium, vitamin D, and vitamin B12.

DEXA Bone Mineral Density Scan: Recommended at diagnosis due to secondary hyperparathyroidism and malabsorption of calcium and vitamin D.

Pneumococcal Vaccination: Due to functional hyposplenism secondary to splenic atrophy seen in chronic coeliac disease.

Irritable Bowel Syndrome (IBS)

Irritable bowel syndrome (IBS) is a chronic functional disorder of brain-gut interaction characterized by recurrent abdominal pain associated with altered bowel habits, in the complete absence of detectable organic structural pathology.

Rome IV Diagnostic Criteria

Recurrent abdominal pain on average at least 1 day per week in the last 3 months , associated with two or more of the following criteria:

  • Related to defecation (either improved or worsened by bowel movement)
  • Associated with a change in stool frequency
  • Associated with a change in stool form (appearance)

Symptoms must have started at least 6 months prior to diagnosis and be currently active during the past 3 months.

Subtypes (Bristol Stool Form Scale)

IBS-D (Diarrhoea-predominant): > 25 % > 25\% > 25% loose/watery stools (Bristol 6-7), < 25 % < 25\% < 25% hard stools.

IBS-C (Constipation-predominant): > 25 % > 25\% > 25% hard/lumpy stools (Bristol 1-2), < 25 % < 25\% < 25% loose stools.

IBS-M (Mixed bowel habits): > 25 % > 25\% > 25% hard stools and > 25 % > 25\% > 25% loose stools.

IBS-U (Unclassified): Insufficient stool abnormality to meet above criteria.

Alarm Features ('Red Flags')

The presence of any of the following features excludes uncomplicated IBS and warrants urgent specialist referral and organic evaluation (colonoscopy and CT imaging):

  • Age of onset > 50 years > 50\text{ years} > 50 years
  • Unexplained, involuntary weight loss
  • Rectal bleeding or melaena (in the absence of documented bleeding haemorrhoids/fissures)
  • Nocturnal diarrhoea awakening the patient from sleep
  • Persistent, progressive, severe symptoms or unexplained fever
  • Unexplained iron deficiency anaemia or elevated inflammatory markers (CRP/ESR)
  • Family history of colorectal cancer, IBD, or coeliac disease in a first-degree relative
  • Palpable abdominal or rectal mass, or lymphadenopathy
  • Diagnostic Workup in the Absence of Red Flags

In young patients meeting Rome IV criteria without red flags, extensive invasive investigations are unnecessary. Baseline non-invasive tests include:

  • Full Blood Count (FBC) & Ferritin (rules out anaemia)
  • C-Reactive Protein (CRP) (rules out active systemic inflammation)
  • Coeliac Serology (anti-tTG IgA + total serum IgA)

Faecal calprotectin: A low result makes significant intestinal inflammation less likely in the right setting, but does not provide a universal exclusion. Alarm features, persistent symptoms and pre-test probability still guide investigation.

Evidence-Based Management Strategies

Doctor-Patient Relationship: Validate symptoms, explain the gut-brain axis, visceral hypersensitivity, and the benign prognosis.

Dietary Approaches: Structured trial of a Low-FODMAP diet (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) supervised by a specialized dietitian. Trial of soluble fibre (ispaghula / psyllium husk) for IBS-C; avoid insoluble fibre (wheat bran), which exacerbates bloating.

Pharmacological Interventions:

Antispasmodics: Mebeverine, hyoscine butylbromide, or peppermint oil capsules taken prior to meals for postprandial cramping.

IBS-D: Loperamide as needed for loose stools; low-dose tricyclic antidepressants (TCAs) (e.g. amitriptyline 10 − 25 mg 10-25\text{ mg} 10 − 25 mg nocte) to modulate visceral hypersensitivity and slow gut transit.

IBS-C: Osmotic laxatives (macrogol / polyethylene glycol); avoid stimulant laxatives long term; selective serotonin reuptake inhibitors (SSRIs) if comorbid anxiety or depression.

Psychological Interventions: Gut-directed hypnotherapy and cognitive behavioural therapy (CBT) for refractory symptoms.

Primary references (checked 7 October 2026): Coeliac Australia oats guidance .

Coeliac Australia gluten challenge explains preparation for testing.